Patient Guide: Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07187960
Status: NOT_YET_RECRUITING
Condition: Follicular Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Beijing, Beijing Municipality
  • • Chongqing, Chongqing Municipality
  • • Lanzhou, Gansu
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma - Join Clinical Trial NCTNCT07187960

How to Join This Clinical Trial - NCTNCT07187960

Learn how to participate in this PHASE3 trial studying an investigational therapy for Follicular Lymphoma. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Follicular Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Follicular Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07187960 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing Municipality 100142 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing Municipality 400010 - China

Status: Contact for availability

Clinical Research Site

Lanzhou, Gansu 730030 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510700 - China

Status: Contact for availability

Clinical Research Site

Guiyang, Guizhou 550004 - China

Status: Contact for availability

Clinical Research Site

Haikou, Hainan 570311 - China

Status: Contact for availability

Clinical Research Site

Harbin, Heilongjiang 150081 - China

Status: Contact for availability

Clinical Research Site

Zhengzhou, Henan 450000 - China

Status: Contact for availability

Clinical Research Site

Zhengzhou, Henan 450000 - China

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430079 - China

Status: Contact for availability

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Follicular Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships